Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company

Email

error message

Password

error message

By submitting this information, I give consent to the Association of European Businesses (AEB) (address: 68/70 Butyrsky Val St., Bldg. 1, 4th Floor, Premises I, Room 7, Tverskoy Municipal District, Moscow, 127055 Russian Federation) for the processing (collection, recording, systematization, accumulation, storage, clarification [update, change], extraction, use, transfer [provision, access, entrusting processing] to third parties [including companies providing storage of data from the information system and its maintenance], blocking, deletion, and destruction using automation tools or without them) of my personal data for the purpose of interacting with the AEB and receiving informational materials from the AEB. My personal data for which this consent is given includes my last name, first name, gender, and contact information (including email). My consent is valid for 5 years and can be revoked by sending a corresponding request to the address of the AEB. If I provide another person's data, I must ensure that the consent of that person is obtained prior to submitting the data.

Remember me Forgot password?

Search

Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company